Published in J Infect Dis on December 01, 1977
Neutralization test in influenza: use in individuals without hemagglutination inhibition antibody. J Clin Microbiol (1979) 1.97
Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults. Clin Diagn Lab Immunol (1996) 1.36
Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice. Virology (2012) 1.16
Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines. Rev Med Virol (2012) 1.11
Detection of influenza virus neuraminidase-specific antibodies by an enzyme-linked immunosorbent assay. J Clin Microbiol (1982) 1.01
Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines. Vaccine (2012) 0.99
Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations. Infect Immun (1980) 0.98
A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus. PLoS One (2011) 0.96
Purified viral neuraminidase vaccine to control influenza. Can Med Assoc J (1979) 0.87
Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med (1977) 25.00
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ (1973) 10.70
The epidemiology of AIDS: current status and future prospects. Science (1985) 8.73
Cytotoxic T-cell immunity to influenza. N Engl J Med (1983) 8.49
An outbreak of influenza aboard a commercial airliner. Am J Epidemiol (1979) 5.51
The Hong Kong-68 influenza A2 variant. Lancet (1968) 5.25
Association of antigenic type of Herpesvirus hominis with site of viral recovery. J Immunol (1967) 5.07
Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health (1987) 4.87
Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology (1990) 4.71
A serologic study of herpesvirus hominis strains by microneutralization tests. J Immunol (1967) 4.39
Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA (1985) 3.85
Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. J Virol (1983) 3.70
Immunization policies and vaccine coverage among adults. The risk for missed opportunities. Ann Intern Med (1988) 3.49
The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene. Virology (1986) 3.34
Antigenic and biologic differences in herpesvirus hominis. Prog Med Virol (1968) 3.31
Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response. Br Med J (1972) 3.10
Characterization and evaluation of monoclonal antibodies developed for typing influenza A and influenza B viruses. J Clin Microbiol (1986) 3.04
The epidemiology of AIDS. Public Health Rep (1983) 3.00
Swine influenza viruses isolated in 1976 from man and pig contain two coexisting subpopulations with antigenically distinguishable hemagglutinins. Virology (1977) 2.90
Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2). Virology (1988) 2.62
Antigenic similarity of influenza A (H1N1) viruses from epidemics in 1977--1978 to "Scandinavian" strains isolated in epidemics of 1950--1951. Virology (1978) 2.61
Analysis of antigenic drift in recently isolated influenza A (H1N1) viruses using monoclonal antibody preparations. Virology (1979) 2.45
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. Infect Immun (1980) 2.42
Antigenicity and evolution amongst recent influenza viruses of H1N1 subtype. Nucleic Acids Res (1983) 2.41
Genital infection with type 2 Herpes virus hominis. A commonly occurring venereal disease. Br J Vener Dis (1969) 2.40
Current CDC efforts to prevent and control human immunodeficiency virus infection and AIDS in the United States through information and education. Public Health Rep (1988) 2.40
Relation of pock size on chorioallantoic membrane to antigenic type of herpesvirus hominis. Proc Soc Exp Biol Med (1968) 2.34
Rapid detection of influenza virus by shell vial assay with monoclonal antibodies. J Clin Microbiol (1986) 2.31
Monoclonal antibodies for the rapid diagnosis of influenza A and B virus infections by immunofluorescence. Lancet (1985) 2.30
Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses. Bull World Health Organ (1969) 2.28
Adult pneumonia in a general hospital. Etiology and host risk factors. Arch Intern Med (1972) 2.24
Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection. J Clin Microbiol (1988) 2.22
Effect of neuraminidase antibody on Hong Kong influenza. Lancet (1973) 2.11
Isolation of swine influenza virus from autopsy lung tissue of man. N Engl J Med (1976) 2.09
Stopping poliovirus vaccination after eradication: issues and challenges. Bull World Health Organ (2000) 2.00
Risk factors for outbreaks of influenza in nursing homes. A case-control study. Am J Epidemiol (1986) 1.93
Recombination of human influenza A viruses in nature. Nature (1980) 1.92
Laboratory-based surveillance of influenza A(H1N1) and A(H3N2) viruses in 1980-81: antigenic and genomic analyses. Bull World Health Organ (1983) 1.89
Identification and preliminary antigenic analysis of swine influenza-like viruses isolated during an influenza outbreak at Fort Dix, New Jersey. J Infect Dis (1977) 1.88
Sensitivity and specificity of enzyme immunoassay for serodiagnosis of influenza A virus infections. J Infect Dis (1980) 1.86
Association of cervical cytomegaloviruses with venereal disease. N Engl J Med (1973) 1.84
Cold adapted variants of influenza A. II. Comparison of the genetic and biological properties of ts mutants and recombinants of the cold adapted A/AA/6/60 strain. Arch Virol (1977) 1.81
Natural history of influenza type A in the United States, 1957-1972. Prog Med Virol (1974) 1.79
Summary of clinical trials of inactivated influenza vaccine - 1978. Rev Infect Dis (1983) 1.79
Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis (1993) 1.69
Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus. J Gen Virol (1992) 1.69
Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. Bull World Health Organ (1974) 1.68
Studies with avian influenza A viruses: cross protection experiments in chickens. J Gen Virol (1971) 1.66
Protein composition of coronavirus OC 43. Virology (1972) 1.66
Spontaneous cytomegalovirus mononucleosis. Clinical and laboratory observations in nine cases. Ann Intern Med (1973) 1.65
A nationwide outbreak of Reye's Syndrome. Its epidemiologic relationship of influenza B. Am J Med (1976) 1.64
A comparison of "influenza C" with prototype myxoviruses: receptor-destroycing activity (neuraminidase) and structural polypeptides. Virology (1975) 1.63
Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2). Am J Epidemiol (1991) 1.62
Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in man. Am J Epidemiol (1970) 1.60
Genetic and antigenic analyses of influenza A (H1N1) viruses, 1986-1991. Virus Res (1993) 1.59
WHO collaborative study on the sero-epidemiology of rubella in Caribbean and Middle and South American populations in 1968. Bull World Health Organ (1970) 1.58
The next influenza pandemic: lessons from Hong Kong, 1997. Emerg Infect Dis (1999) 1.58
Age-related heterologous antibody responses to influenza virus vaccination. J Infect Dis (1977) 1.57
Time-resolved fluoroimmunoassay with monoclonal antibodies for rapid diagnosis of influenza infections. J Clin Microbiol (1986) 1.56
Inactivated influenza vaccines. 2. Laboratory indices of protection. Postgrad Med J (1973) 1.56
Coronaviridae. Intervirology (1975) 1.55
Antigenic and genomic analyses of influenza A(H1N1) viruses from different regions of the world, February 1978 to March 1980. Infect Immun (1981) 1.55
Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy. Bull World Health Organ (1969) 1.55
Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain. Infect Immun (1979) 1.51
Swine influenza virus infections in humans. J Infect Dis (1977) 1.50
Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child. J Virol (1991) 1.47
Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immunocompromised child. Am J Epidemiol (1984) 1.47
Identification of the binding sites to monoclonal antibodies on A/USSR/90/77 (H1N1) hemagglutinin and their involvement in antigenic drift in H1N1 influenza viruses. Virology (1983) 1.45
Seroepidemiologic survey of coronavirus (strain OC 43) related infections in a children's population. Am J Epidemiol (1971) 1.44
Pathways of evolution of influenza A (H1N1) viruses from 1977 to 1986 as determined by oligonucleotide mapping and sequencing studies. J Gen Virol (1989) 1.43
Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes. Antimicrob Agents Chemother (1984) 1.42
Properties of the Hong Kong influenza virus. Antigenic relationship of the Hong Kong virus haemagglutinin to that of other human influenza A viruses. Bull World Health Organ (1969) 1.41
Bear meat trichinosis. Epidemiologic, serologic, and clinical observations from two Alaskan outbreaks. Ann Intern Med (1972) 1.40
Epidemiology of influenza in the elderly: evidence of virus recycling. Am J Epidemiol (1976) 1.40
An outbreak of influenza A/Taiwan/1/86 (H1N1) infections at a naval base and its association with airplane travel. Am J Epidemiol (1989) 1.39
Increased sensitivity and reduced specificity of hemagglutination inhibition tests with ether-treated influenza B/Singapore/222/79. J Clin Microbiol (1983) 1.39
Pathogenicity of influenza A/Seal/Mass/1/80 virus mutants for mammalian species. Arch Virol (1995) 1.38
Genital infection with Herpesvirus hominis types 1 and 2 in children. Pediatrics (1968) 1.38
Genetic stability of A/Ann Arbor/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers. J Infect Dis (1984) 1.37
Laboratory-based surveillance of influenza virus in the United States during the winter of 1977--1978. II. Isolation of a mixture of A/Victoria- and A/USSR-like viruses from a single person during an epidemic in Wyoming, USA, January 1978. Am J Epidemiol (1979) 1.37
Further studies of the antigenic properties of H3N2 strains of influenza A isolated from swine in South East Asia. J Gen Virol (1979) 1.35
Risk factors for improper vaccine storage and handling in private provider offices. Pediatrics (2001) 1.33
Influenza neuraminidase antibody patterns of man. Am J Epidemiol (1973) 1.32
Antigenic variants of influenza B virus. Br Med J (1973) 1.31
Evaluation of a cold-recombinant influenza virus vaccine in ferrets. J Infect Dis (1982) 1.31
Antibody response to the M2 protein of influenza A virus expressed in insect cells. J Gen Virol (1993) 1.31
Temperature-sensitive mutants of influenza A virus: evaluation of A/Victoria/3/75-ts-1[E] recombinant viruses in volunteers. Infect Immun (1978) 1.30